Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nora Navone

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Cell Reports|February 24, 2017
Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 SignalingStyliani Karanika, Theodoros Karantanos, Likun Li, et al.
Oncogene|September 29, 2021
Prostate cancer castrate resistant progression usage of non-canonical androgen receptor signaling and ketone body fuelEstefania Labanca, Juan Bizzotto, Pablo Sanchis, et al.
Prostate Cancer and Prostatic Diseases|September 13, 2022
Characterization of prostate cancer adrenal metastases: dependence upon androgen receptor signaling and steroid hormonesMinas J Sakellakis, Andrew W Hahn, Sumankalai Ramachandran, et al.
American Journal of Clinical and Experimental Urology|December 27, 2023
Role of adenosine deaminase in prostate cancer progressionChristy Charles, Stacy M Lloyd, Danthasinghe Waduge Badrajee Piyarathna, et al.
Cell Death & Disease|February 4, 2018
Game-changing restraint of Ros-damaged phenylalanine, upon tumor metastasisGeraldine Gueron, Nicolás Anselmino, Paula Chiarella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2017
Targeting the MYCN-PARP-DNA Damage Response Pathway in Neuroendocrine Prostate CancerWei Zhang, Bo Liu, Wenhui Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2021
Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone MicroenvironmentIoulia Vardaki, Paul Corn, Emanuela Gentile, et al.
Cancer Research|January 30, 2014
PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancerJohn R Prensner, Wei Chen, Matthew K Iyer, et al.
Science Signaling|May 22, 2014
Targeting poly(ADP-ribose) polymerase and the c-Myb-regulated DNA damage response pathway in castration-resistant prostate cancerLikun Li, Wenjun Chang, Guang Yang, et al.
Science Translational Medicine|December 3, 2011
Personalized oncology through integrative high-throughput sequencing: a pilot studySameek Roychowdhury, Matthew K Iyer, Dan R Robinson, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Cell Reports|February 24, 2017
Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 SignalingStyliani Karanika, Theodoros Karantanos, Likun Li, et al.
Oncogene|September 29, 2021
Prostate cancer castrate resistant progression usage of non-canonical androgen receptor signaling and ketone body fuelEstefania Labanca, Juan Bizzotto, Pablo Sanchis, et al.
Prostate Cancer and Prostatic Diseases|September 13, 2022
Characterization of prostate cancer adrenal metastases: dependence upon androgen receptor signaling and steroid hormonesMinas J Sakellakis, Andrew W Hahn, Sumankalai Ramachandran, et al.
American Journal of Clinical and Experimental Urology|December 27, 2023
Role of adenosine deaminase in prostate cancer progressionChristy Charles, Stacy M Lloyd, Danthasinghe Waduge Badrajee Piyarathna, et al.
Cell Death & Disease|February 4, 2018
Game-changing restraint of Ros-damaged phenylalanine, upon tumor metastasisGeraldine Gueron, Nicolás Anselmino, Paula Chiarella, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2017
Targeting the MYCN-PARP-DNA Damage Response Pathway in Neuroendocrine Prostate CancerWei Zhang, Bo Liu, Wenhui Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2021
Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone MicroenvironmentIoulia Vardaki, Paul Corn, Emanuela Gentile, et al.
Cancer Research|January 30, 2014
PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancerJohn R Prensner, Wei Chen, Matthew K Iyer, et al.
Science Signaling|May 22, 2014
Targeting poly(ADP-ribose) polymerase and the c-Myb-regulated DNA damage response pathway in castration-resistant prostate cancerLikun Li, Wenjun Chang, Guang Yang, et al.
Science Translational Medicine|December 3, 2011
Personalized oncology through integrative high-throughput sequencing: a pilot studySameek Roychowdhury, Matthew K Iyer, Dan R Robinson, et al.
Pageof 5